💊
Abraxane
paclitaxel
Neoplasias da mama;Neoplasias pancreáticas;Carcinoma de pulmão de células não pequenas
✅ Autorizado
✅
Nenhum alerta ativo
Este medicamento não apresenta escassez contínua, cartas de segurança ou recolhimentos.
Para que serve
Abraxane monotherapy is indicated for the treatment of metastatic breast cancer in adult patients who have failed first-line treatment for metastatic disease and for whom standard, anthracycline containing therapy is not indicated. Abraxane in combination with gemcitabine is indicated for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas. Abraxane in combination with carboplatin is indicated for the first-line treatment of non-small cell lung cancer in adult patients who are not candidates for potentially curative surgery and/or radiation therapy.
⚠️ Segurança do paciente
No
📚 Alertas anteriores (2)
Página oficial da EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/abraxane